PT - JOURNAL ARTICLE AU - Bishop, James H. AU - Faerman, Afik AU - Geoly, Andrew AU - Khan, Naushaba AU - Tischler, Claudia AU - Amin, Heer AU - Maron-Katz, Adi AU - Azeez, Azeezat AU - Yeomans, David C. AU - Hurd, Ralph AU - Gu, Meng AU - Baltusis, Laima AU - Spielman, Daniel AU - Sacchet, Matthew D. AU - Spiegel, David AU - Williams, Nolan TI - Altered Neurotransmitter Ratio in the Prefrontal Cortex is Associated with Pain in Fibromyalgia Syndrome AID - 10.1101/2021.10.28.21265618 DP - 2021 Jan 01 TA - medRxiv PG - 2021.10.28.21265618 4099 - http://medrxiv.org/content/early/2021/10/29/2021.10.28.21265618.short 4100 - http://medrxiv.org/content/early/2021/10/29/2021.10.28.21265618.full AB - The central mechanisms underlying fibromyalgia syndrome (FMS) remain undetermined. The dorsolateral prefrontal cortex (DLPFC) is particularly relevant to FMS because it is implicated in cognitive, affective, and top-down pain regulation. Imbalances in excitatory (Glutamate) and inhibitory (Gamma aminobutyric acid; GABA) neurochemicals may play a critical role in the pathophysiology of the condition and more generally in homeostatic function within cortical circuits. Although the balance of excitation and inhibition are intrinsically linked no investigations to date have investigated the E/I ratio in FMS. Thus, the primary objective of this study was to determine whether the E/I ratio in the DLPFC is altered in participants with FMS compared to healthy controls using magnetic resonance spectroscopy. Additionally, we examined the relationship between E/I ratio and pain metrics. We hypothesized that the E/I ratio within the DLPFC would be altered in participants with FMS compared to controls and, secondly, that E/I ratio would be associated with both clinical pain and thermal pain sensitivity. The Brief Pain Inventory (BPI) self-assessment was used to evaluate pain severity and impact on physical functioning and acute pain sensitivity was determined via quantitative sensory testing to define thermal (heat) pain threshold and tolerance. Our results revealed an elevation in the E/I ratio in FMS compared to controls. A positive relationship between E/I ratio and thermal pain sensitivity measures was identified in the FMS cohort. Collapsing across groups, there was a positive relationship between E/I ratio and BPI score. These findings suggest that dysfunction in the balance between excitation and inhibition within cognitive brain circuitry may play a role in pain processing in FMS.Competing Interest StatementDr. Williams is a named inventor on Stanford-owned intellectual property relating to neuroimaging-based TMS targeting; he has served on scientific advisory boards for Otsuka, NeuraWell, Nooma, and Halo. The other authors declare no competing financial or conflicts of interests.Funding StatementThis work was supported by the NIH National Center for Complementary and Integrative Health grants 5R33AT009305-03 (NW/DS) and 1F32AT010420-01 (JB). The Stanford University Molecular Imaging Scholars Fellowship (T32CA118681; JB) and the Center for Neurobiological Imaging Innovation Award (JB).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Stanford University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.